Recombinant Human CDH1/E-Cadherin/CD324 Protein
Référence MBS9146712-0,01mg
Conditionnement : 0.01mg
Marque : MyBiosource
CDH1/E-Cadherin/CD324 (CDH1) Human Recombinant Protein
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9146712Recombinant Human CDH1/E-Cadherin/CD324 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Asp155-Ala709) of human E-Cadherin/Cadherin-1 (Accession #NP_004351.1) fused with a 6×His tag at the C-terminus. More details
Product Overview
Product Name
CDH1/E-Cadherin/CD324, Recombinant Protein
Full Product Name
Recombinant Human CDH1/E-Cadherin/CD324 Protein
Product Gene Name
CDH1 recombinant protein
Product Synonym Gene Name
CD324
Product Synonym Names
Arc-1; CD324; CDHE; ECAD; LCAM; UVO; CDH1; E-Cadherin; Arc-1; CD324; CDHE; ECAD; LCAM; UVO; cadherin-1; E Cadherin
Host
HEK293 cells
Form/Format
Liquid
Lyophilized from a 0.22 um filtered solution of PBS, pH 7.4.
Lyophilized from a 0.22 um filtered solution of PBS, pH 7.4.
Purity/Purification
> 95% by SDS-PAGE.
Preparation and Storage
Store the lyophilized protein at -20 to -80 degree C for 12 months. After reconstitution, the protein solution is stable at -20 degree C for 3 months, at 2-8 degree C for up to 1 week. Avoid repeated freeze/thaw cycles.
Ship: Ice Pack
Ship: Ice Pack
Molecular Weight
97,456 Da
Chromosome Location
Chromosome: 16; NC_000016.9 (68771195..68869444). Location: 16q22.1
OMIM
137215
Species
Human
Endotoxin
< 0.1 EU/ug of the protein by LAL method.
Tag
C-His
Bioactivity
1. Measured by its binding ability in a functional ELISA. Immobilized Human CDH1 at 1 ug/mL (100 uL/well) can bind Human CTNNB1 with a linear range of 0.1-0.78 ug/mL.
2. Measured by the ability of the immobilized protein to support the adhesion of MCF-7 human breast adenocarcinoma cells. When cells are added to E-Cad coated plates (5 ug/mL, 100 uL/well), >12 % will adhere specifically after 90 minutes at 37 degree C.
2. Measured by the ability of the immobilized protein to support the adhesion of MCF-7 human breast adenocarcinoma cells. When cells are added to E-Cad coated plates (5 ug/mL, 100 uL/well), >12 % will adhere specifically after 90 minutes at 37 degree C.
Product Categories/Family for CDH1 recombinant protein
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Other Notes
Small volumes of CDH1 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for CDH1 purchase
MBS9146712 is a recombinant protein targeting CDH1. Also known as Recombinant Human CDH1/E-Cadherin/CD324 Protein. Host: HEK293 cells.
Additional Details
NCBI/Uniprot data below describe general gene information for CDH1. It may not necessarily be applicable to this product.
NCBI Official Full Name
cadherin-1 preproprotein
NCBI Official Synonym Full Names
cadherin 1, type 1, E-cadherin (epithelial)
NCBI Official Symbol
CDH1
NCBI Official Synonym Symbols
UVO; CDHE; ECAD; LCAM; Arc-1; CD324
UniProt Protein Name
Cadherin-1
UniProt Synonym Protein Names
CAM 120/80; Epithelial cadherin; E-cadherin; Uvomorulin
Protein Family
Anaphase-promoting complex
UniProt Gene Name
CDH1
UniProt Synonym Gene Names
CDHE; UVO; E-cadherin
UniProt Entry Name
CADH1_HUMAN
NCBI Protein Information
cadherin-1; CAM 120/80; E-Cadherin; uvomorulin; cell-CAM 120/80; epithelial cadherin; cadherin 1, E-cadherin (epithelial); calcium-dependent adhesion protein, epithelial
NCBI Summary for CDH1
This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for CDH1
CDH1: a single-pass type I membrane protein, and calcium dependent cell adhesion proteins. It is a ligand for integrin alpha-E/beta-7, and it colocalizes with DLG7 at sites of cell-cell contact in intestinal epithelial cells. Anchored to actin microfilaments through association with alpha-, beta- and gamma-catenin. Sequential proteolysis induced by apoptosis or calcium influx, results in translocation from sites of cell-cell contact to the cytoplasm. Involved in mechanisms regulating cell-cell adhesions, mobility and proliferation of epithelial cells. Defects in CDH1 are involved in dysfunction of the cell-cell adhesion system, triggering cancer invasion (gastric, breast, ovary, endometrium and thyroid) and metastasis. Has a potent invasive suppressor role.
Protein type: Cell adhesion; Motility/polarity/chemotaxis; Membrane protein, integral; Ubiquitin ligase
Chromosomal Location of Human Ortholog: 16q22.1
Cellular Component: apical junction complex; internal side of plasma membrane; focal adhesion; cell surface; lateral loop; basolateral plasma membrane; extracellular region; integral to membrane; trans-Golgi network; catenin complex; actin cytoskeleton; cell-cell adherens junction; apical part of cell; perinuclear region of cytoplasm; cytoplasm; plasma membrane; nerve terminal; cell junction; endosome; lateral plasma membrane
Molecular Function: protein domain specific binding; protein binding; gamma-catenin binding; beta-catenin binding; GTPase activating protein binding; calcium ion binding; cell adhesion molecule binding; ankyrin binding; glycoprotein binding; protein phosphatase binding
Biological Process: response to drug; intercellular junction assembly and maintenance; extracellular matrix organization and biogenesis; regulation of immune response; apoptosis; response to toxin; positive regulation of transcription, DNA-dependent; regulation of caspase activity; trophectodermal cell differentiation; regulation of water loss via skin; extracellular matrix disassembly; cell-cell adhesion; synaptogenesis; sensory perception of sound; pituitary gland development; calcium-dependent cell-cell adhesion; protein metabolic process; positive regulation of transcription factor import into nucleus; negative regulation of cell-cell adhesion; homophilic cell adhesion; protein homooligomerization; neurite development; negative regulation of epithelial cell proliferation; cell structure disassembly during apoptosis
Disease: Gastric Cancer, Hereditary Diffuse; Prostate Cancer; Breast Cancer; Ovarian Cancer; Endometrial Cancer
Show more Protein type: Cell adhesion; Motility/polarity/chemotaxis; Membrane protein, integral; Ubiquitin ligase
Chromosomal Location of Human Ortholog: 16q22.1
Cellular Component: apical junction complex; internal side of plasma membrane; focal adhesion; cell surface; lateral loop; basolateral plasma membrane; extracellular region; integral to membrane; trans-Golgi network; catenin complex; actin cytoskeleton; cell-cell adherens junction; apical part of cell; perinuclear region of cytoplasm; cytoplasm; plasma membrane; nerve terminal; cell junction; endosome; lateral plasma membrane
Molecular Function: protein domain specific binding; protein binding; gamma-catenin binding; beta-catenin binding; GTPase activating protein binding; calcium ion binding; cell adhesion molecule binding; ankyrin binding; glycoprotein binding; protein phosphatase binding
Biological Process: response to drug; intercellular junction assembly and maintenance; extracellular matrix organization and biogenesis; regulation of immune response; apoptosis; response to toxin; positive regulation of transcription, DNA-dependent; regulation of caspase activity; trophectodermal cell differentiation; regulation of water loss via skin; extracellular matrix disassembly; cell-cell adhesion; synaptogenesis; sensory perception of sound; pituitary gland development; calcium-dependent cell-cell adhesion; protein metabolic process; positive regulation of transcription factor import into nucleus; negative regulation of cell-cell adhesion; homophilic cell adhesion; protein homooligomerization; neurite development; negative regulation of epithelial cell proliferation; cell structure disassembly during apoptosis
Disease: Gastric Cancer, Hereditary Diffuse; Prostate Cancer; Breast Cancer; Ovarian Cancer; Endometrial Cancer
Research Articles on CDH1
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with CDH1 recombinant protein
| Reference Product | PubMed Publications |
|---|---|
| CTNNB1 recombinant protein | >106 publications with CDH1 and CTNNB1 |
| EGFR recombinant protein | >26 publications with CDH1 and EGFR |
| ZEB1 recombinant protein | >26 publications with CDH1 and ZEB1 |
| CASP8 recombinant protein | >16 publications with CDH1 and CASP8 |
| CTNNA1 recombinant protein | >7 publications with CDH1 and CTNNA1 |
| CASP3 recombinant protein | >6 publications with CDH1 and CASP3 |
| HDAC1 recombinant protein | >4 publications with CDH1 and HDAC1 |
| NEDD9 recombinant protein | >3 publications with CDH1 and NEDD9 |
| JUP recombinant protein | >3 publications with CDH1 and JUP |
| HDAC2 recombinant protein | >3 publications with CDH1 and HDAC2 |
Pathways associated with CDH1 recombinant protein
| Products by Pathway | Pathway Diagram |
|---|---|
| Adaptive Immune System Pathway antibodies | Adaptive Immune System Pathway Diagram |
| Adherens Junction Pathway antibodies | Adherens Junction Pathway Diagram |
| Adherens Junction Pathway antibodies | Adherens Junction Pathway Diagram |
| Adherens Junctions Interactions Pathway antibodies | Adherens Junctions Interactions Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| Apoptotic Cleavage Of Cell Adhesion Proteins Pathway antibodies | Apoptotic Cleavage Of Cell Adhesion Proteins Pathway Diagram |
| Apoptotic Cleavage Of Cellular Proteins Pathway antibodies | Apoptotic Cleavage Of Cellular Proteins Pathway Diagram |
| Apoptotic Execution Phase Pathway antibodies | Apoptotic Execution Phase Pathway Diagram |
| Arf6 Trafficking Events Pathway antibodies | Arf6 Trafficking Events Pathway Diagram |
| Bacterial Invasion Of Epithelial Cells Pathway antibodies | Bacterial Invasion Of Epithelial Cells Pathway Diagram |
Diseases associated with CDH1 recombinant protein
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >791 publications with CDH1 and Neoplasms |
| Carcinoma Antibodies | >382 publications with CDH1 and Carcinoma |
| Stomach Neoplasms Antibodies | >248 publications with CDH1 and Stomach Neoplasms |
| Breast Neoplasms Antibodies | >190 publications with CDH1 and Breast Neoplasms |
| Neoplasm Metastasis Antibodies | >97 publications with CDH1 and Neoplasm Metastasis |
| Neoplasm Invasiveness Antibodies | >93 publications with CDH1 and Neoplasm Invasiveness |
| Colorectal Neoplasms Antibodies | >88 publications with CDH1 and Colorectal Neoplasms |
| Disease Progression Antibodies | >81 publications with CDH1 and Disease Progression |
| Liver Neoplasms Antibodies | >49 publications with CDH1 and Liver Neoplasms |
| Carcinoma, Squamous Cell Antibodies | >48 publications with CDH1 and Carcinoma, Squamous Cell |
Organs/Tissues associated with CDH1 recombinant protein
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Stomach Antibodies | >260 publications with CDH1 and Stomach |
| Blood Antibodies | >85 publications with CDH1 and Blood |
| Lymph Node Antibodies | >69 publications with CDH1 and Lymph Node |
| Lung Antibodies | >60 publications with CDH1 and Lung |
| Liver Antibodies | >58 publications with CDH1 and Liver |
| Brain Antibodies | >47 publications with CDH1 and Brain |
| Prostate Antibodies | >40 publications with CDH1 and Prostate |
| Kidney Antibodies | >35 publications with CDH1 and Kidney |
| Embryonic Tissue Antibodies | >32 publications with CDH1 and Embryonic Tissue |
| Bladder Antibodies | >22 publications with CDH1 and Bladder |



